Pseudocyesis: A complication of antipsychotic-induced increased prolactin levels and weight gain
Mrs. X, a 46-year-old woman presented with an acute onset illness, continuous in course of 2-month duration, which started about 2 months after the death of her only son in a road traffic accident, characterized by liability of effect, delusion of persecution, visual hallucinations, regressed behavior, restlessness, irritability, disorganized behavior, muttering to self, decreased sleep, decreased appetite and poor self-care. There was no history of first rank symptoms, grandiosity, core depressive symptoms, any substance abuse, head injury, seizures, loss of consciousness and cognitive disturbances. There was no family history of mental illness, and premorbidly the patient had histrionic traits. Initially, a diagnosis of Acute and Transient Psychotic Disorder (acute polymorphic psychotic disorder without symptoms of schizophrenia) (as per ICD-10) was considered and she was started on risperidone up to 3 mg/day, but her condition kept worsening resulting in hospitalization. At the initial evaluation her weight was 83 kilograms, height was 158 cm and waist circumference was 102.5 cm. Routine investigations and computed tomography of the brain did not reveal any abnormality. In view of non-response to 4 weeks of therapy, risperidone was stopped and she was started on olanzapine up to 20 mg/day, with which she initially showed response, and was discharged after 5 weeks. However, within 2 weeks she had worsening of symptoms leading to re-admission. Due to the florid symptoms, she was started on electroconvulsive therapy and antipsychotic was changed to trifluperazine 15 mg/day. A diagnostic possibility of psychosis (not otherwise specified) (as per ICD-10) was considered. Her psychotic symptoms stabilized with trifluperazine and ECT, but she developed depressive symptoms after stoppage of ECT, amounting to moderate depressive episode without somatic features (as per ICD-10) and required treatment with sertraline 100 mg/day. With this combination she remained well for 14 months. Although she did not achieve her premorbid self, her residual negative symptoms did not interfere much with her level of functioning. During the stable phase, her body weight, waist circumference, lipid profile and fasting blood sugar levels remained stable. However, initially reported irregular menstrual cycles and later developed amenorrhea and galactorrhea on investigation was found to have significant increase in serum prolactin levels (150 ng/ml). Tab trifluperazine was crossed tapered with tab quetiapine, which was increased to 300 mg/day. With starting of quetiapine, she started gaining weight and her waist circumference increased significantly. While cross-tapering was being done, she started having relapse of symptoms of psychosis. The symptoms kept on worsening despite increase in the dose of quetiapine to 600 mg/day along with clonazepam 6 mg/day with good compliance. The relapse also coincided with the death anniversary of her son. The symptomatology of the current episode was very similar to the previous episode, but additionally she had delusion of pregnancy. She reported that she is pregnant, is able to perceive the movements of the fetus and is shortly going to deliver a male child. When anybody tried to tell her against the same, she would become irritable and violent. Persistence of symptoms with quetiapine led to third admission. On mental status examination, she held the belief of being pregnant firmly and could not be convinced against the same. While in the hospital at times she reported pain in the abdomen and would say that she was having labor pain and is going to give birth to a male child. She would also go to pass urine frequently, would demand for healthy food traditionally given to pregnant mothers and would walk by protruding her abdomen.\nAt this time, her body weight was 96 kilograms and waist circumference was 138 cm. Her lipid profile revealed raised triglyceride levels and reduced high density lipoprotein levels. Ultrasound abdomen revealed bulky uterus with multiple fibroids with no fetal sac and repeat serum prolactin levels were 89.5 ng/ml and 76.55 ng/ml on 2 different occasions 2 weeks apart. All other investigations including urine pregnancy test, thyroid function test and serum cortisol levels were done in consultation with the gynecologist and endocrinologist, which were found to be within normal limits. During the hospital stay, she very firmly held the belief that she is pregnant even though she had her menstrual periods. She would often ask the treating team to shift her to the maternity ward. She was initially managed with tab ziprasidone up to 120 mg/day along with electroconvulsive therapy. Although she showed some improvement in her positive symptoms with this treatment, delusion of pregnancy persisted at the same intensity. Increase in dose of ziprasidone to 140 mg/day led to changes in the electrocardiogram and resultantly it was stopped. After giving all the available options, patient's husband opted for clozapine. After proper evaluation, she was started on clozapine and the dose was gradually increased to 200 mg/day, with which she achieved remission with no further increase in body weight and waist circumference over the period of 12 weeks of therapy. Remission was also accompanied with normalization of serum prolactin levels. After remission, she acknowledged that she had false belief of being pregnant.